← Leaderboards
Prakash Srinivasan
Johns Hopkins University
$2,533,213
Attributed
$4,159,166
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,159,166 · 4
By mechanism
R01$2,802,178 · 1
R21$1,356,988 · 3
Top collaborators
- Danielle Stanisic4 shared
- Nathan Schmidt2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Nirbhay Kumar$12,253,206
- Danielle Stanisic$1,401,089
- Gary W Ketner$3,064,527
- Matthew Michael Ippolito$3,648,189
- Richard B. Markham$15,441,953
Others in their field
Other Emerging Leaders on “Child”
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,898,304
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Beth Baseler · Leidos Biomedical Research, Inc.$22,470,677
- Gaurav J Dave · Duke University$17,082,764
Research focus
ChildPlasmodium FalciparumVaccinesInfectionParasitesVaccine CandidateCessation Of LifeProteinsPre-ClinicalPlasmodiumAdjuvantIn VitroResponsePreventComplexMediatingAntigensMalaria VaccinesImmune ResponseMalariaBloodParasite ResistanceProtective EfficacyImmunogenicity
Grant awards (10)
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum$697,101
R01 · FY2025 · AI · contact PI
Effect of gut microbiota composition on malaria vaccine-induced immune responses$194,728
R21 · FY2025 · AI
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum$748,920
R01 · FY2024 · AI · contact PI
Effect of gut microbiota composition on malaria vaccine-induced immune responses$255,000
R21 · FY2024 · AI
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum$672,371
R01 · FY2023 · AI · contact PI
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum$683,786
R01 · FY2022 · AI · contact PI
ARCHAEAL-DERIVED SELF ADJUVANTING NANOPARTICLE MALARIA VACCINE$202,375
R21 · FY2020 · AI · contact PI
ARCHAEAL-DERIVED SELF ADJUVANTING NANOPARTICLE MALARIA VACCINE$254,625
R21 · FY2019 · AI · contact PI
ENGINEERING A SELF-TARGETING ENTRY INHIBITOR FOR VECTORED MALARIA PROPHYLAXIS$245,625
R21 · FY2019 · AI · contact PI
ENGINEERING A SELF-TARGETING ENTRY INHIBITOR FOR VECTORED MALARIA PROPHYLAXIS$204,635
R21 · FY2018 · AI · contact PI